These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29367704)

  • 41. Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes.
    Vatier C; Kalbasi D; Vantyghem MC; Lascols O; Jéru I; Daguenel A; Gautier JF; Buyse M; Vigouroux C
    Orphanet J Rare Dis; 2019 Jul; 14(1):177. PubMed ID: 31300002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy.
    Simha V; Zerwekh JE; Sakhaee K; Garg A
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4942-5. PubMed ID: 12414854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.
    Ebihara K; Kusakabe T; Hirata M; Masuzaki H; Miyanaga F; Kobayashi N; Tanaka T; Chusho H; Miyazawa T; Hayashi T; Hosoda K; Ogawa Y; DePaoli AM; Fukushima M; Nakao K
    J Clin Endocrinol Metab; 2007 Feb; 92(2):532-41. PubMed ID: 17118991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular mechanisms associated with leptin resistance: n-3 polyunsaturated fatty acids induce alterations in the tight junction of the brain.
    Oh-I S; Shimizu H; Sato T; Uehara Y; Okada S; Mori M
    Cell Metab; 2005 May; 1(5):331-41. PubMed ID: 16054080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progranulin is increased in human and murine lipodystrophy.
    Miehle K; Ebert T; Kralisch S; Hoffmann A; Kratzsch J; Schlögl H; Stumvoll M; Fasshauer M
    Diabetes Res Clin Pract; 2016 Oct; 120():1-7. PubMed ID: 27497155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need.
    Polyzos SA; Mantzoros CS
    Curr Med Res Opin; 2022 Jun; 38(6):885-888. PubMed ID: 35352624
    [No Abstract]   [Full Text] [Related]  

  • 47. Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy.
    Liu L; Jiang Q; Wang X; Zhang Y; Lin RC; Lam SM; Shui G; Zhou L; Li P; Wang Y; Cui X; Gao M; Zhang L; Lv Y; Xu G; Liu G; Zhao D; Yang H
    Diabetes; 2014 Jul; 63(7):2320-31. PubMed ID: 24622797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effects of Leptin Replacement on Neural Plasticity.
    Paz-Filho GJ
    Neural Plast; 2016; 2016():8528934. PubMed ID: 26881138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy.
    Cook K; Adamski K; Gomes A; Tuttle E; Kalden H; Cochran E; Brown RJ
    J Endocr Soc; 2021 Apr; 5(4):bvab019. PubMed ID: 33817539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Membrane topology of the human seipin protein.
    Lundin C; Nordström R; Wagner K; Windpassinger C; Andersson H; von Heijne G; Nilsson I
    FEBS Lett; 2006 Apr; 580(9):2281-4. PubMed ID: 16574104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How to diagnose a lipodystrophy syndrome.
    Vantyghem MC; Balavoine AS; Douillard C; Defrance F; Dieudonne L; Mouton F; Lemaire C; Bertrand-Escouflaire N; Bourdelle-Hego MF; Devemy F; Evrard A; Gheerbrand D; Girardot C; Gumuche S; Hober C; Topolinski H; Lamblin B; Mycinski B; Ryndak A; Karrouz W; Duvivier E; Merlen E; Cortet C; Weill J; Lacroix D; Wémeau JL
    Ann Endocrinol (Paris); 2012 Jun; 73(3):170-89. PubMed ID: 22748602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Metreleptin Effectiveness and Safety Registry (MEASuRE): concept, design and challenges.
    Haymond MW; Araújo-Vilar D; Balser J; Lewis JH; Louzado R; Musso C; von Schnurbein J; Wabitsch M;
    Orphanet J Rare Dis; 2023 May; 18(1):127. PubMed ID: 37237416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
    Agarwal AK; Simha V; Oral EA; Moran SA; Gorden P; O'Rahilly S; Zaidi Z; Gurakan F; Arslanian SA; Klar A; Ricker A; White NH; Bindl L; Herbst K; Kennel K; Patel SB; Al-Gazali L; Garg A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4840-7. PubMed ID: 14557463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic basis of congenital generalized lipodystrophy.
    Agarwal AK; Barnes RI; Garg A
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):336-9. PubMed ID: 14557833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Seipin/BSCL2-related motor neuron disease: Seipinopathy is a novel conformational disease associated with endoplasmic reticulum stress].
    Ito D; Suzuki N
    Rinsho Shinkeigaku; 2007 Jun; 47(6):329-35. PubMed ID: 17633104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report.
    Nagayama A; Ashida K; Moritaka K; Hidaka M; Gobaru M; Tanaka S; Hasuzawa N; Akasu S; Goto Y; Motomura S; Hara K; Tsuruta M; Wada N; Nakayama H; Tajiri Y; Nomura M
    J Endocr Soc; 2019 Nov; 3(11):2179-2183. PubMed ID: 31720553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.
    Sienkiewicz E; Magkos F; Aronis KN; Brinkoetter M; Chamberland JP; Chou S; Arampatzi KM; Gao C; Koniaris A; Mantzoros CS
    Metabolism; 2011 Sep; 60(9):1211-21. PubMed ID: 21741057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
    Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
    Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seipin is necessary for normal brain development and spermatogenesis in addition to adipogenesis.
    Ebihara C; Ebihara K; Aizawa-Abe M; Mashimo T; Tomita T; Zhao M; Gumbilai V; Kusakabe T; Yamamoto Y; Aotani D; Yamamoto-Kataoka S; Sakai T; Hosoda K; Serikawa T; Nakao K
    Hum Mol Genet; 2015 Aug; 24(15):4238-49. PubMed ID: 25934999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.